Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention

BACKGROUND: With 2.5 million new HIV infections per year, effective preventive methods against HIV are urgently needed, especially in sub-Saharan Africa. MDP301 is an ongoing trial of the vaginal microbicide PRO 2000/5 being conducted by the Microbicides Development Programme. The main objective of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nunn, Andrew, McCormack, Sheena, Crook, Angela M, Pool, Robert, Rutterford, Clare, Hayes, Richard
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2774685/
https://www.ncbi.nlm.nih.gov/pubmed/19860888
http://dx.doi.org/10.1186/1745-6215-10-99

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2774685/
https://www.ncbi.nlm.nih.gov/pubmed/19860888
http://dx.doi.org/10.1186/1745-6215-10-99

Ejemplares similares